Spire to Present at Piper Jaffray Clean Technology & Renewables Conference

Business Wire, Feb 15, 2008

Company to Webcast Presentation on February 20

BEDFORD, Mass. -- Spire Corporation (Nasdaq: SPIR), a global solar company providing turnkey solar factories and capital equipment to manufacture photovoltaic modules, cells, and wafers worldwide, today announced that its senior management will be presenting at the Third Annual Piper Jaffray Clean Technology & Renewables Conference at the New York Palace Hotel in New York, NY on Wednesday, February 20th at 4:00 p.m. (ET).

At the conference, Mr. Roger Little, Chairman and CEO of Spire Corporation, will discuss Spire's business strategy and review the company's recent accomplishments. Also attending will be Mr. Mark Little, CEO of the company's Spire Biomedical subsidiary and Director of Investor Relations, Spire Corporation's COO Mr. Rodger LaFavre, and CFO and Treasurer, Dr. Christian Dufresne. The presentation will be broadcast live over the Internet. Those interested in listening to the live webcast should log on to the "Investors" section of Spire Corporation's website, www.spirecorp.com prior to the event.

About Spire Corporation

Spire Corporation is a global solar company providing turnkey production lines and capital equipment to manufacture photovoltaic modules worldwide. Spire Semiconductor develops and manufactures custom GaAs solar cells and other related products for the commercial, biomedical and defense markets. The company's Spire Biomedical subsidiary is a leader in hemodialysis catheters and implantable device processing services.

For corporate or product information, contact Spire Corporation, "The Turnkey Solar Factory Company", at 781-275-6000, or visit www.spirecorp.com.

Certain matters described in this news release may be forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risk of dependence on market growth, competition and dependence on government agencies and other third parties for funding contract research and services, as well as other factors described in the Company's Form 10-KSB and other periodic reports filed with the Securities and Exchange Commission.